Navigation Links
Pharmaceutical Industry Places Newfound Emphasis on Managed Care Organizations
Date:1/23/2012

CHAPEL HILL, N.C., Jan. 23, 2012 /PRNewswire/ -- As the influence of Managed Care continues to grow, so too do the activities that biopharma companies carry out as part of interacting with the managed care sector. Consequently, pharmaceutical and medical device leaders have placed an increased importance on these activities, as the strength of these organizations has become closely intertwined with marketplace success.

On average, the Best Practices, LLC benchmark class drastically increased investment levels to $3 million per FTE in 2010 compared to one-half million in 2003. To meet the needs of Managed Care leaders trying to defend their resource and investment levels, Best Practices, LLC conducted a comprehensive research study to identify the industry standards for staffing data (FTE), outsourcing, budget and efficiency metrics.

In addition, relative to 2003, Managed Care groups increased the percentage of budget allocated for payor pricing activity by 13% in 2010, according to "Resource Benchmarks for U.S. Pharmaceutical Managed Care Operations," a new primary research study conducted by Best Practices, LLC.

Download a complimentary white paper at http:/www.best-in-class.com/rr1141.htm that includes selected best practices drawn from extensive primary research with 12 participants, ranging from senior leaders to managers of managed markets, from 10 leading bio-pharma and medical device companies.

Study topics include:


SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  TeamHealth Medical Call Center (THMCC), a premier ... lines, announces its newly formed Clinical Advisory Committee. ... leaders, provides clinical expertise to advance THMCC,s purpose ... hospital clients, physician clients and patients. ... imperative to continuously advance our services and improve ...
(Date:5/23/2013)... Calif. , May 23, 2013 Anthem ... program that would have required them to obtain their ... by Consumer Watchdog and Whatley Kallas LLC.  ... Superior Court, alleged that Blue Cross,s mandatory mail order ... threatening their health and privacy. "This settlement ...
(Date:5/23/2013)... , May 23, 2013  Spring Bank Pharmaceuticals, ... treatment of viral infections, today announced that it has ... 9200, its investigational, once daily, oral therapy for the ... healthy, HCV-infected patients and is designed to assess both ... 9200 is a first-in-class drug for the treatment of ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3
... 23, 2007 - CytoGenix, Inc. (CYGX.OB),announced today that ... update on preclinical animal data for DNA vaccines ... 2007,DNA Vaccines conference to be held in Malaga, ... comments, "We have successfully conducted tests of,synDNA(TM) based ...
... VANCOUVER, British Columbia--(BUSINESS WIRE)--May 23, 2007 -,ProtoKinetix Inc. ... by ITTEC Stem, Inc. at the University of ... for stem cells demonstrate the vital importance of ... This is the,first series of tests using AAGP(TM) ...
Cached Medicine Technology:CytoGenix to Present at 2007 International DNA Vaccines Conference,in Spain 2ProtoKinetix's AAGP Dramatically Increases Recovery Rate of,Cryopreserved Stem Cells 2
(Date:5/23/2013)... dragged to its destruction inside a cell, a ... that thwart the development of tumor-suppressing microRNAs (miRNAs) ... online publication at Nature . , Under ... the epidermal growth factor receptor (EGFR) gums up ... by scientists at The University of Texas MD ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 ... C.R. Bard, Inc., continue to move forward in a ... District of West Virginia, Bernstein Liebhard LLP reports. ... denied a request by C.R. Bard to seal emails ... trade secrets and other confidential, proprietary information about its ...
(Date:5/23/2013)... New York, NY (PRWEB) May 23, 2013 ... http://bit.ly/Z4m6UI , Canadian tech start-ups are increasingly seeing ... deals with larger US-based companies, according to ... business development engine. , The company has compiled ... entitled Borderless Investments. The findings of the research have ...
(Date:5/23/2013)... May 23, 2013 EnvirOasis, the leader ... and ESCO market is pleased to announce its new ... Listed LED products. EnvirOasis has been a market ... and retrofit kits and has recently brought to market ... (Light Emitting Diode) is energy efficient lighting technology which ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) ... as badly as methamphetamine or crack cocaine, a new ... ,meth mouth, or ,coke mouth, it is startling to ... less the same," said Dr. Mohamed Bassiouny, a professor ... Dentistry in Philadelphia. Methamphetamine, crack cocaine and soda ...
Breaking Medicine News(10 mins):Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 4Health News:EnvirOasis Lighting Announces Energy Star and Design Lights Consortium LED Products 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3
... SOUTH SAN FRANCISCO, Calif., July 7 Catalyst Biosciences, ... research and license agreement with MedImmune, the global biologics ... that specifically degrade or modulate two targets, one of ... , Catalyst will receive undisclosed upfront licensing fees, full-time ...
... is a fully equipped bio-safety level 2 laboratory dedicated exclusively ... Affairs for Medizone. "This new laboratory is located in ... the country and will provide a primary research and development ... now a clear path to commercialization with its lead product, ...
... 2009 AMERIGROUP Corporation (NYSE: AGP ) today ... quarter ended June 30, 2009, at approximately 6:00 a.m. Eastern ... Eastern Time on the same day, AMERIGROUP,s management will host ... information. , , To listen to the call, dial ...
... GROVE, Ill., July 7 Lifeway Foods, Inc. (Nasdaq: ... of other natural and organic dairy products, invites you to come ... the first pitch before the Chicago Cubs take on the Atlanta ... this official "Lifeway Day with the Cubs," the local kefir manufacturer ...
... July 7 CSC (NYSE: CSC ) today ... in multiple categories of Celent,s 2009 Insurance Software Deal Trends ... research and advisory firm, reported in the Life/Health Edition that ... Processing with 56 percent of the deals in 2007 and ...
... 7 Rho Luxfeyr does not want to be labeled as ... that she offers via her Web site ( http://rho-luxfeyr.com ) extend ... tellers focus on predicting the future, which is really no help ... can be constructed or changed by will or intent," said Luxfeyr. ...
Cached Medicine News:Health News:Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics 2Health News:Medizone International, Inc. (MZEI.PK) Announces it has Established its Own BSL2A Certified Laboratory Located in Innovation Park, Queen's University at Kingston, Ontario, Canada. 2Health News:AMERIGROUP Corporation to Discuss Second Quarter Earnings on July 31 2Health News:Giant Bugs Invade Wrigley Field 2Health News:CSC Cited as a Leading Technology Provider in Celent Insurance Software Study 2Health News:Unique Intuitive Service Helps Clients Improve Their Lives 2
... monochromatic and chromatic correction for the focal ... completely flat images for observation and photomicrography ... of wavelengths up to the near UV ... glass types of low autofluorescence makes these ...
... The CFI Fluor 20x Water ... physiology and brain research where the ... exposed living tissue or brain slice. ... bright fluorescent signals with a numberical ...
Inquire...
... 63x/1.25 Oil Ph3 Antiflex is ... contrast. This method reveals structures ... such as cells adhering to ... dish. Moreover, this objective is ...
Medicine Products: